VLAIO Funding

Innovation happens when diverse fields join forces

MEDVIA provides €9 million in earmarked, non-dilutive funding – made available by Flanders Innovation & Entrepreneurship (VLAIO) – to consortia developing disruptive solutions for unmet medical needs.  

Consortia must consist of partners from at least two of the three MEDVIA sectors: medical technology, biotechnology and digital health 

There are two funding calls per year, which we announce on our website, in our newsletter and via our social media.

Current open calls for VLAIO funding

Different needs, different funding options

VLAIO provides multiple kinds of grant options, depending on the partners and the needs of the project.

We help you to understand which option is best and we give optimal support in your application.

Feasibility study

Innovative projects exploring tech and market feasibility. Also open to pre-seed start-ups

Research project

An innovative idea that requires more insight via research to create a new product

Development grant

Development of new or existing product with existing research

Cluster Strategic Basic Research (CSBO)

Innovative research that offers prospects for economic or societal applications such as a new generation of products, processes or services

ICON

Highly innovative, interdisciplinary collaborative research between research institutes and industry. Universities/research centers receive 100% funding

COOCK

Knowledge transfer projects that accelerate the introduction of technology to a broad group of companies through use cases

TETRA

Accelerating the introduction of technology developed by colleges/universities to enterprises and NGOs

Want to know more about funding?

Contact our experts

Get in touch

Not sure which funding option is right for you?

Better together

and are joining forces in a brand new organization

The members of MEDVIA and flanders.bio have voted to merge their activities in the first half of 2025. With a united voice, we will champion the entire healthtech and biotech ecosystem on the regional, federal and European stage.

The merger allows MEDVIA and flanders.bio to align activities and deliver more powerful support for our collective members. We will achieve greater impact with more dynamic networking opportunities, better directed funding and increased efficiency, sharpening our focus in common areas and drafting strategic roadmaps for Flanders.